You are here:

  1. Home
  2. NICE guidance
  3. In development

Neuroendocrine tumours (metastatic, unresectable, progressive) - everolimus and sunitinib [ID858]

  • In development
  • Reference number: GID-TA10024
  • Expected publication date:  28 June 2017
  • Project information
  • Project documents

On this page

  1. Notes
  2. Final appraisal determination
  3. Invitation to participate
  4. Draft scope documents

Documents

Documents created during the development process.

Notes

  • Note

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 335 KB)

    Published:
    12 May 2017
  • Public committee slides (PDF 897 KB)

    Published:
    12 May 2017
  • Public committee slides (PDF 447 KB)

    Published:
    12 May 2017
  • Committee papers (PDF 15.49 MB)

    Published:
    12 May 2017

Invitation to participate

  • Final matrix (PDF 101 KB)

    Published:
    02 June 2016
  • Final protocol (PDF 351 KB)

    Published:
    27 June 2016
  • Final scope (PDF 112 KB)

    Published:
    18 August 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 134 KB)

    Published:
    18 August 2016

Draft scope documents

  • Draft scope (post-referral) (PDF 147 KB)

    Published:
    29 February 2016
  • Provisional matrix (post-referral) (PDF 100 KB)

    Published:
    29 February 2016
Back to top